Welcome to
Alera Bio
Biology drives us.
Patients define us.
Revolutionizing Life-Changing
Therapies for Neurological Conditions
Advancing Science Where It's Needed Most
Alera Bio is a neuroscience-focused biotechnology company based in Chicago, committed to creating transformative treatments for rare and neglected neurological conditions. We bring together scientific rigor, clinical urgency, and innovative thinking to address diseases where few others look—and where families urgently need solutions.
Charting our Path
Alera Bio is actively advancing a development strategy in rare pediatric neurodevelopmental disorders rooted in impaired transport, metabolism, and intracellular signaling—hallmarks of conditions like MCT-8 deficiency. We are pursuing the in-licensing of our lead program targeting this space.
The Alera Approach
Our Focus
Rare pediatric and neurological diseases with high unmet need.
​
Our Patients
Our pipeline will be shaped by urgency, equity, and a pact with patients to deliver meaningful outcomes for children and families living with rare neurological diseases.
​
Our Scientific Approach
Apply an innovation-first mindset to rare CNS disorders and build on validated neurodevelopmental mechanisms with strong translational biology and clear regulatory precedents
Our Business Approach
-
Strength through strategic partnerships
-
Rapid proof-of-concept and early and continued regulatory alignment
-
Focus on capital efficiency, lean operations, and milestone-driven progress
-
Pursue near-term regulatory pathways with clear IP and exclusivity
917 Washington Blvd, #106
Chicago, IL 60607​
​​​​​​​​
844.257.2246
© 2025 by Alero Bio, Inc. | All Rights Reserved